Versant Affiliates
QuietMenlo Park, CAHealthcare, Biotechnology, PharmaceuticalsLast fund filed 2000
7 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| VERSANT AFFILIATES FUND I-A | 2000 | $5.2M | $5.2M | 37 |
| VERSANT AFFILIATES FUND I-B | 2000 | $12M | $12M | 72 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
7 partners are named across this firm’s filings, 7 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Barbara Lubash | Quiet | Healthcare services, Digital health | 4 | 0 |
Classified sectors of Versant Affiliates’s own portfolio companies, based on 44 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Versant Venture Capital | 44 | AcuFocus, ADVANCED ICU CARE, Alexza Pharmaceuticals, Allegro Ophthalmics, Alphaeon, ALTERG, Atreca, CareConnectMD, Cell Design Labs, Ceribell, CERO THERAPEUTICS HOLDINGS, DocMatter, Edwards Lifesciences, Equinox Ophthalmic, FIDELIS SENIORCARE, FIVE PRIME THERAPEUTICS, FLUIDIGM, Immune Design, Inari Medical, Intuity Medical, KINESTRAL TECHNOLOGIES, LENSAR, MINERVA SURGICAL, NEOVISTA, Neurolens, NOVASYS MEDICAL, Okami Medical, OneFocus Vision, OPGEN, ORAMETRIX, Oyster Point Pharma, PHASERX, Prelude, REDBRICK HEALTH, Relievant MedSystems, RENNOVIA, RxSight, Sebacia, SECOND SIGHT MEDICAL PRODUCTS, Sequent Medical, Sympara Medical, TearClear, VERACYTE, ViaLase |
| U.S Venture Partners | 5 | Inari Medical, Intuity Medical, Okami Medical, Sequent Medical, ViaLase |
| Brian Atwood | Quiet | Biotech & pharma, Fintech | 8 | 0 |
| Donald Milder | Quiet | Medical devices | 3 | 0 |
| Rebecca Robertson | Quiet | Medical devices, Digital health, Robotics & hardware | 5 | 0 |
| Ross Jaffe | Quiet | Medical devices, Digital health | 5 | 0 |
| Samuel Colella | Quiet | Biotech & pharma, Climate & energy, Manufacturing & industrials | 5 | 0 |
| William Link | Quiet | Medical devices, Biotech & pharma, Digital health | 16 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Versant Affiliates’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| 3 |
| ADVANCED ICU CARE, FIDELIS SENIORCARE, ViaLase |
| Stack Infrastructure | 3 | Inari Medical, Okami Medical, Sequent Medical |
| Highland Capital Partners | 2 | FIDELIS SENIORCARE, OPGEN |
| Vida Ventures | 2 | Cell Design Labs, VERACYTE |
| Westlake Biopartners | 2 | Cell Design Labs, REDBRICK HEALTH |
| ARCH Venture Partners | 1 | PHASERX |
| Domain Partners | 1 | Sequent Medical |
| Longitude 103.8 East | 1 | Ceribell |
| Longitude Capital | 1 | Ceribell |
| Longitude Prime | 1 | Ceribell |
| SV Life Sciences | 1 | AcuFocus |
| The Column Group | 1 | Immune Design |
| Vivo Innovation | 1 | MINERVA SURGICAL |
A shared board seat: a company where filings name a Versant Affiliates partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.